Chronic Kidney Disease Clinical Trials in Phoenix, Arizona
6 recruitingPhoenix, Arizona
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Chronic Kidney Disease
Boehringer Ingelheim120 enrolled102 locationsNCT07107945
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled178 locationsNCT05457283
Recruiting
Not Applicable
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Chronic Kidney DiseasesArteriovenous FistulaVascular Access Complication+7 more
VenoStent600 enrolled28 locationsNCT06001827
Recruiting
Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuria
Bayer219 enrolled154 locationsNCT05196035
Recruiting
Not Applicable
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Kidney DiseaseType 2 DiabetesChronic Kidney Disease (Stages 4 and 5)
Well Cell Global120 enrolled1 locationNCT07187479
Recruiting
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Diabetes MellitusCardiovascular DiseasesChronic Kidney Diseases+1 more
University of New Mexico500 enrolled3 locationsNCT04185844